Protein kinase-A-dependent osteoprotegerin production on interleukin-1 stimulation in human gingival fibroblasts is distinct from periodontal ligament fibroblasts

Clinical and Experimental Immunology

Volumn 142, Issue 3, 2005, Pages 490-497

  Hormdee, Doosadee ^a   Nagasawa, T ^a   Kiji, M ^a   Yashiro, R ^a   Kobayashi, H ^a   Koshy, G ^a   Noguchi, K ^a   Nitta, H ^a   Ishikawa, I ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

IL 1; OPG; Osteoclast; Periodontitis; RANKL

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLOHEXIMIDE; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROSTAGLANDIN INHIBITOR; PROTEIN KINASE C INHIBITOR;

ADULT; ARTICLE; CELL DIFFERENTIATION; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FIBROBLAST; GINGIVA; HUMAN; HUMAN CELL; MALE; MESENCHYME CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PERIODONTAL LIGAMENT; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOHEXIMIDE; DINOPROSTONE; FEMALE; FIBROBLASTS; GINGIVA; GLYCOPROTEINS; HUMANS; INDOMETHACIN; INTERLEUKIN-1; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OSTEOCLASTS; OSTEOPROTEGERIN; PERIODONTAL LIGAMENT; PROTEIN KINASE C; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER;

EID: 28344452928     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02937.x     Document Type: Article

References (40)

1. Ash P, Loutit JF, Townsend KM. Osteoclasts derived from haematopoietic stem cells. Nature 1980; 283:669-70.
2. Scheven BA, Visser JW, Nijweide PJ. In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature 1986; 321:79-81.
3. Odgren PR, Kim N, MacKay CA et al. The role of RANKL (TRANCE/TNFSF11), a tumor necrosis factor family member, in skeletal development: effects of gene knockout and transgenic rescue. Connect Tissue Res 2003; 44 (Suppl. 1):264-71.
4. Simonet WS, Lacey DL, Dunstan CR et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89:309-19.
5. Yasuda H, Shima N, Nakagawa N et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998; 95:3597-602.
6. Tsuda E, Goto M, Mochizuki S et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 1997; 234:137-42.
7. Yasuda H, Shima N, Nakagawa N et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998; 139:132-7.
8. Halladay DL, Miles RR, Thirunavukkarasu K et al. Identification of signal transduction pathways and promoter sequences that mediate parathyroid hormone 1-38 inhibition of osteoprotegerin gene expression. J Cell Biochem 2001; 84:1-11.
9. Yasuda H, Shima N, Nakagawa N et al. A novel molecular mechanism modulating osteoclast differentiation and function. Bone 1999; 25:109-13.
10. Liu D, Xu JK, Figliomeni L et al. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med 2003; 11:17-21.
11. Nagasawa T, Kobayashi H, Kiji M et al. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Clin Exp Immunol 2002; 130:338-44.
12. Kanamaru F, Iwai H, Ikeda T et al. Expression of membrane-bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells. Immunol Lett 2004; 94:239-46.
13. Kawai T, Eisen-Lev R, Seki M et al. Requirement of B 7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 2000; 164:2102-9.
14. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003; 74:391-11.
15. Hayashi J, Saito I, Ishikawa I et al. Effects of cytokines and period-ontopathic bacteria on the leukocyte function-associated antigen 1/intercellular adhesion molecule 1 pathway in gingival fibroblasts in adult periodontitis. Infect Immun 1994; 62:5205-12.
16. Boch JA, Wara-aswapati N, Auron PE. Interleukin 1 signal trans-duction - current concepts and relevance to periodontitis. J Dent Res 2001; 80:400-7.
17. Hofbauer LC, Lacey DL, Dunstan CR et al. Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999; 25:255-9.
18. Lindhe J, Karring T, Lang PN. Clinical periodontology and implant dentistry, 4th edn. Copenhagen: Blackwell Munksgaard, 2003.
19. Alberts B, Johnson A, Lewis J, Raff M, Robert K, Walter P. Molecular biology of the cell, 4th edn. New York: Galand Science, 2002.
20. Zhang D, Yang YQ, Li XT et al. The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without lalpha, 25-dihydroxyvitamin D3. Arch Oral Biol 2004; 49:71-6.
21. Kanzaki H, Chiba M, Takahashi I et al. Local OPG gene transfer to periodontal tissue inhibits orthodontic tooth movement. J Dent Res 2004; 83:920-5.
22. Kondo H, Guo J, Bringhurst FR. Cyclic adenosine mono-phosphate/protein kinase A mediates parathyroid hormone/ parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. J Bone Miner Res 2002; 17:1667-79.
23. Brandstrom H, Bjorkman T, Ljunggren O. Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells. Biochem Biophys Res Commun 2001; 280:831-5.
24. Wise GE, Ren Y, Yao S. Regulation of osteoprotegerin gene expression in dental follicle cells. J Dent Res 2003; 82:298-302.
25. 2 signalling systems results in enhancement of osteoclastogenesis through effects on the OPG/ RANKL/RANK system. Endocrinology 2005; 146:1991-8.
26. Dinarello CA. The interleukin-1 family: 10 years of discovery. FASEB J 1994; 8:1314-5.
27. Munoz Blanco E. IL-I signal transduction. Immunol Today 1991; 12:287-8.
28. Shirakawa F, Yamashita U, Chedid M et al. Cyclic AMP - an intra-cellular second messenger for interleukin 1. Proc Natl Acad Sci USA 1988; 85:8201-5.
29. Zhang YH, Lin JX, Yip YK et al. Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6. Proc Natl Acad Sci USA 1988; 85:6802-5.
30. Burch RM, Connor JR. Elevated cAMP is required for stimulation of cicosanoid synthesis by interleukin 1 and bradykinin in BALB/c 3T3 fibroblasts. J Cell Physiol 1992; 151:512-8.
31. Weitzmann MN, Savage N. Cyclic adenosine 3',5'-monophosphate, a second messenger in interleukin-1 mediated K562 cytostasis. Biochem Biophys Res Commun 1993; 190:564-70.
32. Munoz E, Beutner U, Zubiaga A et al. IL-1 activates two separate signal transduction pathways in T helper type II cells. J Immunol 1990; 144:964-9.
33. Chedid M, Mizel SB. Involvement of cyclic AMP-dependent protein kinases in the signal transduction pathway for interleukin-1. Mol Cell Biol 1990; 10:3824-7.
34. Lee SK, Lorenzo JA. Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. Bone 2002; 31:252-9.
35. Fu Q, Jilka RL, Manolagas SC et al. Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. J Biol Chem 2002; 277:48868-5.
36. Sakata M, Shiba H, Komatsuzawa H et al. Osteoprotegerin levels increased by interleukin-1eta in human periodontal ligament cells are suppressed through prostaglandin E(2) synthesized de novo. Cytokine 2002; 18:133-9.
37. 2 is crucially involved in lipopolysac-charide-induced osteoclast formation. J Immunol 2004; 172:2504-10.
38. Noguchi K, Shitashige M, Ishikawa I. Involvement of cyclooxyge-nase-2 in interleukin-1alpha-induced prostaglandin production by human periodontal ligament cells. J Periodontol 1999; 70:902-8.
39. Kostenuik PJ, Shalhoub V. Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. Gurr Pharm Des 2001; 7:613-35.
40. Soames JV, Entwisle DN, Davies RM. The progression of gingivitis to periodontitis in the beagle dog: a histological and morphometric investigation. J Periodontol 1976; 47:435-9.